메뉴 건너뛰기




Volumn 16, Issue 2, 1998, Pages 664-669

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: A southwest oncology group study

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; DACARBAZINE; TAMOXIFEN;

EID: 0031896003     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.664     Document Type: Article
Times cited : (49)

References (29)
  • 1
    • 0017159791 scopus 로고
    • Eastern Cooperative Oncology Group studies with DTIC (NSC-45388)
    • Carbone P, Costello W: Eastern Cooperative Oncology Group studies with DTIC (NSC-45388). Cancer Treat Rep 60:1287-1295, 1976
    • (1976) Cancer Treat Rep , vol.60 , pp. 1287-1295
    • Carbone, P.1    Costello, W.2
  • 2
    • 0015465092 scopus 로고
    • Phase II evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) in patients with solid tumors
    • Ramirez G, Wilson W, Grage T, et al: Phase II evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) in patients with solid tumors. Cancer Treat Rep 56:787-790, 1972
    • (1972) Cancer Treat Rep , vol.56 , pp. 787-790
    • Ramirez, G.1    Wilson, W.2    Grage, T.3
  • 3
    • 0026551390 scopus 로고
    • Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials
    • McClay EF, Mastrangelo MJ, Berd D, et al: Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials. Int J Cancer 50:553-556, 1992
    • (1992) Int J Cancer , vol.50 , pp. 553-556
    • McClay, E.F.1    Mastrangelo, M.J.2    Berd, D.3
  • 4
    • 0024504718 scopus 로고
    • The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma
    • McClay EF, Mastrangelo MJ, Sprandio JD, et al: The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma. Cancer 63:1292-1295, 1989
    • (1989) Cancer , vol.63 , pp. 1292-1295
    • McClay, E.F.1    Mastrangelo, M.J.2    Sprandio, J.D.3
  • 5
    • 0029917778 scopus 로고    scopus 로고
    • The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma
    • Flaherty LE, Liu PY, Mitchell MS, et al: The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. Am J Clin Oncol 19:108-113, 1996
    • (1996) Am J Clin Oncol , vol.19 , pp. 108-113
    • Flaherty, L.E.1    Liu, P.Y.2    Mitchell, M.S.3
  • 6
    • 0004993453 scopus 로고
    • Comparison of patient characteristics and outcome between a single institution and cooperative group phase II trial in metastatic melanoma with identical eligibility
    • abstr 1352
    • Flaherty L, Liu PY, Smith D, et al: Comparison of patient characteristics and outcome between a single institution and cooperative group phase II trial in metastatic melanoma with identical eligibility. Proc Am Soc Clin Oncol 13:397, 1994 (abstr 1352)
    • (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 397
    • Flaherty, L.1    Liu, P.Y.2    Smith, D.3
  • 7
    • 0027050761 scopus 로고
    • Modulation of cisplatin resistance in human malignant melanoma cells
    • McClay EF, Albright KD, Jones JA, et al: Modulation of cisplatin resistance in human malignant melanoma cells. Cancer Res 52:6790-6796, 1992
    • (1992) Cancer Res , vol.52 , pp. 6790-6796
    • McClay, E.F.1    Albright, K.D.2    Jones, J.A.3
  • 8
    • 0027533945 scopus 로고
    • Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells
    • McClay EF, Albright KD, Jones JA, et al: Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells. Cancer Res 53:1571-1576, 1993
    • (1993) Cancer Res , vol.53 , pp. 1571-1576
    • McClay, E.F.1    Albright, K.D.2    Jones, J.A.3
  • 9
    • 0026625695 scopus 로고
    • Treatment of metastatic malignant with dacarbazine plus tamoxifen
    • Cocconi G, Bella M, Calabresi F, et al: Treatment of metastatic malignant with dacarbazine plus tamoxifen. N Engl J Med 327:516-523, 1992
    • (1992) N Engl J Med , vol.327 , pp. 516-523
    • Cocconi, G.1    Bella, M.2    Calabresi, F.3
  • 10
    • 0025293764 scopus 로고
    • Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: A review
    • Wadler S, Schwartz EL: Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: A review. Cancer Res 3473-3486, 1990
    • (1990) Cancer Res , pp. 3473-3486
    • Wadler, S.1    Schwartz, E.L.2
  • 11
    • 0021702431 scopus 로고
    • Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma
    • Del Prete SA, Maurer LH, O'Donnell J, et al: Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep 68:1403-1405, 1984
    • (1984) Cancer Treat Rep , vol.68 , pp. 1403-1405
    • Del Prete, S.A.1    Maurer, L.H.2    O'Donnell, J.3
  • 12
    • 0023217283 scopus 로고
    • Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma
    • McClay EF, Mastrangelo MJ, Bellet RE, et al: Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma. Cancer Treat Rep 71:465-469, 1987
    • (1987) Cancer Treat Rep , vol.71 , pp. 465-469
    • McClay, E.F.1    Mastrangelo, M.J.2    Bellet, R.E.3
  • 13
    • 0029097550 scopus 로고
    • Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up
    • Lattanzi SC, Tosteson T, Cliertoff J, et al: Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. Melanoma Res 5:365-369, 1995
    • (1995) Melanoma Res , vol.5 , pp. 365-369
    • Lattanzi, S.C.1    Tosteson, T.2    Cliertoff, J.3
  • 14
    • 0026046196 scopus 로고
    • High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma
    • Buzaid AC, Murren JR, Durivage HJ: High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma. Cancer 68:1238-1241, 1991
    • (1991) Cancer , vol.68 , pp. 1238-1241
    • Buzaid, A.C.1    Murren, J.R.2    Durivage, H.J.3
  • 15
    • 0344566351 scopus 로고
    • High dose tamoxifen does not enhance the activity of dacarbazine in metastatic melanoma: QMP9105
    • abstr 1339
    • Thomson DB, Walpole ET, Beadle GF, et al: High dose tamoxifen does not enhance the activity of dacarbazine in metastatic melanoma: QMP9105. Proc Am Soc Clin Oncol 12:392, 1993 (abstr 1339)
    • (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 392
    • Thomson, D.B.1    Walpole, E.T.2    Beadle, G.F.3
  • 16
    • 0345049896 scopus 로고
    • Tamoxifen does not improve response when added to chemotherapy in metastatic melanoma. An Italian trials in medical oncology
    • abstr 1345
    • Bajetta E, Zampino MG, Noie F, et al: Tamoxifen does not improve response when added to chemotherapy in metastatic melanoma. An Italian trials in medical oncology. Proc Am Soc Clin Oncol 12:393, 1993 (abstr 1345)
    • (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 393
    • Bajetta, E.1    Zampino, M.G.2    Noie, F.3
  • 17
    • 0344538063 scopus 로고
    • Carboplatin (C) and dacarbazine (D) ± tamoxifen (T) for metastatic melanoma
    • abstr 1358
    • Ferri W, Kirkwood JM, Vlock D, et al: Carboplatin (C) and dacarbazine (D) ± tamoxifen (T) for metastatic melanoma. Proc Am Soc Clin Oncol 12:396, 1993 (abstr 1358)
    • (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 396
    • Ferri, W.1    Kirkwood, J.M.2    Vlock, D.3
  • 18
    • 0001137782 scopus 로고
    • Short course, high-dose tamoxifen (TAM) with cytotoxic chemotherapy for metastatic melanoma
    • abstr 1016
    • Berd D, McLaughlin CJ, Hart E, et al: Short course, high-dose tamoxifen (TAM) with cytotoxic chemotherapy for metastatic melanoma. Proc Am Soc Clin Oncol 10:291, 1991 (abstr 1016)
    • (1991) Proc Am Soc Clin Oncol , vol.10 , pp. 291
    • Berd, D.1    McLaughlin, C.J.2    Hart, E.3
  • 19
    • 0344187668 scopus 로고
    • Lack of benefit from tamoxifen (T) added to a regimen of cisplatin (C), vinblastine (V), DTIC (D) and alpha interferon (IFN) in patients (PT) with metastatic melanoma (MM)
    • abstr 1325
    • Legha S, Ring S, Bedikian A, et al: Lack of benefit from tamoxifen (T) added to a regimen of cisplatin (C), vinblastine (V), DTIC (D) and alpha interferon (IFN) in patients (PT) with metastatic melanoma (MM). Proc Am Soc Clin Oncol 12:388, 1993 (abstr 1325)
    • (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 388
    • Legha, S.1    Ring, S.2    Bedikian, A.3
  • 20
    • 0013569012 scopus 로고    scopus 로고
    • A randomized phase III trial of dacarbazine (DTIC) versus DTlC + interferon alfa-2b (IFN) versus DTIC + tamoxifen (TMX) versus DTIC + IFN + TMX in metastatic malignant melanoma: An ECOG trial
    • abstr 1350
    • Falkson CI, Ibrahim J, Kirkwood J, et al: A randomized phase III trial of dacarbazine (DTIC) versus DTlC + interferon alfa-2b (IFN) versus DTIC + tamoxifen (TMX) versus DTIC + IFN + TMX in metastatic malignant melanoma: An ECOG trial. Proc Am Soc Clin Oncol 15:435, 1996 (abstr 1350)
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 435
    • Falkson, C.I.1    Ibrahim, J.2    Kirkwood, J.3
  • 21
    • 8944261598 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma
    • Rusthoven JJ, Quirt IC, Iscoe NA, et al: Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. J Clin Oncol 14:2083-2090, 1996
    • (1996) J Clin Oncol , vol.14 , pp. 2083-2090
    • Rusthoven, J.J.1    Quirt, I.C.2    Iscoe, N.A.3
  • 22
    • 0027280177 scopus 로고
    • Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma
    • Fletcher WS, Daniels SD, Sondak VK, et al: Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. Am J Clin Oncol 16:359-362, 1993
    • (1993) Am J Clin Oncol , vol.16 , pp. 359-362
    • Fletcher, W.S.1    Daniels, S.D.2    Sondak, V.K.3
  • 23
    • 0000365082 scopus 로고    scopus 로고
    • Phase III trial of Melacine melanoma theraccine versus combination chemotherapy in the treatment of stage IV melanoma
    • abstr
    • Mitchell MS, Von Eschen KB: Phase III trial of Melacine melanoma theraccine versus combination chemotherapy in the treatment of stage IV melanoma. Proc Am Soc Clin Oncol 16:494, 1997 (abstr)
    • (1997) Proc Am Soc Clin Oncol , vol.16 , pp. 494
    • Mitchell, M.S.1    Von Eschen, K.B.2
  • 24
    • 0010552593 scopus 로고
    • Alpha interferon and chemo-hormonal therapy in advanced melanoma: A phase I-II NBSG/MAOP study
    • abstr 1341
    • Stark JJ, Schulof R, Wiemann M, et al: Alpha interferon and chemo-hormonal therapy in advanced melanoma: A phase I-II NBSG/MAOP study. Proc Am Soc Clin Oncol 12:392, 1993 (abstr 1341)
    • (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 392
    • Stark, J.J.1    Schulof, R.2    Wiemann, M.3
  • 25
    • 0029040035 scopus 로고
    • Phase II trial of recombinant interferon-α with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma
    • Feun LG, Savaraj N, Moffat F, et al: Phase II trial of recombinant interferon-α with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma. Melanoma Res 5:273-276, 1995
    • (1995) Melanoma Res , vol.5 , pp. 273-276
    • Feun, L.G.1    Savaraj, N.2    Moffat, F.3
  • 26
    • 0013613001 scopus 로고
    • A phase-II study of biochemotherapy using interleukin-2 (IL-2) + interferon alfa-2a (IFN) in combination with cisplatin (C), vinblastine (V), and DTIC (D) in patients with metastatic melanoma
    • abstr 1179
    • Legha S, Plager C, Ring S, et al: A phase-II study of biochemotherapy using interleukin-2 (IL-2) + interferon alfa-2a (IFN) in combination with cisplatin (C), vinblastine (V), and DTIC (D) in patients with metastatic melanoma. Proc Am Soc Clin Oncol 11:343, 1992 (abstr 1179)
    • (1992) Proc Am Soc Clin Oncol , vol.11 , pp. 343
    • Legha, S.1    Plager, C.2    Ring, S.3
  • 27
    • 0026734180 scopus 로고
    • Sequential chemoimmunotherapy in the treatment of metastatic melanoma
    • Richards JM, Mehta N, Ramming K, et al: Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J Clin Oncol 10:1338-1343, 1992
    • (1992) J Clin Oncol , vol.10 , pp. 1338-1343
    • Richards, J.M.1    Mehta, N.2    Ramming, K.3
  • 28
    • 0027486041 scopus 로고
    • Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma
    • Khayat D, Borel C, Tourani JM, et al: Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma. J Clin Oncol 11:2173-2180, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 2173-2180
    • Khayat, D.1    Borel, C.2    Tourani, J.M.3
  • 29
    • 0004646475 scopus 로고    scopus 로고
    • BCNU (B), cisplatin (C), dacarbazine (D) and tamoxifen (T) (BCDT) in metastatic melanoma (MM): Results of a randomized phase II study
    • abstr 1782
    • Chiarion Sileni V, Nortilli R, Medici M, et al: BCNU (B), cisplatin (C), dacarbazine (D) and tamoxifen (T) (BCDT) in metastatic melanoma (MM): results of a randomized phase II study. Proc Am Soc Clin Oncol 16:495a, 1997 (abstr 1782)
    • (1997) Proc Am Soc Clin Oncol , vol.16
    • Chiarion Sileni, V.1    Nortilli, R.2    Medici, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.